This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lundin, L. Articles by Theodorsson-Norheim, E. Search for Related Content PubMed PubMed Citation Articles by Lundin, L. Articles by Theodorsson-Norheim, E.

Circulation, Vol 77, 264-269, Copyright © 1988 by American Heart Association

ARTICLES

Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities

L Lundin, I Norheim, J Landelius, K Oberg and E Theodorsson-Norheim
Department of Cardiology, University Hospital, Uppsala, Sweden.

Cardiac ultrasound investigation of 68 prospectively studied patients with histologically proven midgut carcinoid tumors showed right heart disease in 66%. The abnormal findings included morphologic and functional aberrations of the tricuspid valve in 52% and 83%, respectively, right atrial and ventricular enlargement in 53% and 30%, and paradoxical systolic septal contractions in 19%. The patients with the most pronounced right heart disease had significantly higher (p less than .01) plasma levels of the tachykinins neuropeptide K and substance P as well as higher (p less than .001) urinary excretion of the serotonin metabolite 5-hydroxyindoleacetic acid. These patients also had the most extensive tumor disease. The occurrence of echocardiographic abnormalities of the left heart was similar to that in healthy individuals of the same age, but abnormalities were less frequent among the patients with severe right heart disease. Electrocardiographic changes were nonspecific. Right heart disease thus seems to be present more often than previously reported in patients with malignant midgut carcinoid tumors. The severity of cardiac involvement does not seem to be related to the duration of carcinoid disease but more to the extent of the disease, i.e., higher plasma levels of serotonin and tachykinins.

This article has been cited by other articles:

				J. G. Castillo, F. Filsoufi, D. H. Adams, J. Raikhelkar, B. Zaku, and G. W. Fischer Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist Br. J. Anaesth., November 1, 2008; 101(5): 618 - 626. [Abstract] [Full Text] [PDF]

				A. M. Bernheim, H. M. Connolly, J. Rubin, J. E. Moller, C. G. Scott, D. M. Nagorney, and P. A. Pellikka Role of Hepatic Resection for Patients With Carcinoid Heart Disease Mayo Clin. Proc., February 1, 2008; 83(2): 143 - 150. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1111 - 1128. [Full Text]

				S. Bhattacharyya, J. Davar, G. Dreyfus, and M. E. Caplin Carcinoid Heart Disease Circulation, December 11, 2007; 116(24): 2860 - 2865. [Full Text] [PDF]

				F. Majeed, T. R. Porter, S. Tarantolo, A. Duhachek-Stapelman, F. Xie, and A. Elhendy Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome Eur J Echocardiogr, October 1, 2007; 8(5): 386 - 389. [Abstract] [Full Text] [PDF]

				J. E. Moller, P. A. Pellikka, A. M. Bernheim, H. V. Schaff, J. Rubin, and H. M. Connolly Prognosis of Carcinoid Heart Disease: Analysis of 200 Cases Over Two Decades Circulation, November 22, 2005; 112(21): 3320 - 3327. [Abstract] [Full Text] [PDF]

				B. I. Gustafsson, K. Tommeras, I. Nordrum, J. P. Loennechen, A. Brunsvik, E. Solligard, R. Fossmark, I. Bakke, U. Syversen, and H. Waldum Long-Term Serotonin Administration Induces Heart Valve Disease in Rats Circulation, March 29, 2005; 111(12): 1517 - 1522. [Abstract] [Full Text] [PDF]

				J. M. Zuetenhorst and B. G. Taal Metastatic Carcinoid Tumors: A Clinical Review Oncologist, February 1, 2005; 10(2): 123 - 131. [Abstract] [Full Text] [PDF]

				J. E. Moller, H. M. Connolly, J. Rubin, J. B. Seward, K. Modesto, and P. A. Pellikka Factors Associated with Progression of Carcinoid Heart Disease N. Engl. J. Med., March 13, 2003; 348(11): 1005 - 1015. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1001 - 1015. [Full Text]

				M. H. Kulke and R. J. Mayer Carcinoid Tumors N. Engl. J. Med., March 18, 1999; 340(11): 858 - 868. [Full Text] [PDF]

				A. P. Fishman Aminorex to Fen/Phen : An Epidemic Foretold Circulation, January 12, 1999; 99(1): 156 - 161. [Full Text] [PDF]

				W. D. Denney, W. E. Kemp Jr., L. B. Anthony, J. A. Oates, and B. F. Byrd III Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1017 - 1022. [Abstract] [Full Text] [PDF]

				K. Öberg Carcinoid Tumors: Current Concepts in Diagnosis and Treatment Oncologist, October 1, 1998; 3(5): 339 - 345. [Abstract] [Full Text]

				S. S. Kushwaha, J. T. Fallon, and V. Fuster Restrictive Cardiomyopathy N. Engl. J. Med., January 23, 1997; 336(4): 267 - 276. [Full Text] [PDF]

				P. A. Robiolio, V. H. Rigolin, J. S. Wilson, J. K. Harrison, L. L. Sanders, T. M. Bashore, and J. M. Feldman Carcinoid Heart Disease : Correlation of High Serotonin Levels With Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography Circulation, August 15, 1995; 92(4): 790 - 795. [Abstract] [Full Text]

				S. Morelli, C. Perrone, and G. Valesini Tricuspid Valve Steno-Insufficiency in Systemic Lupus Erythematosus Lupus, August 1, 1995; 4(4): 318 - 320. [Abstract] [PDF]

				CARDIAC INVOLVEMENT COMMON IN CARCINOID SYNDROME Journal Watch (General), February 26, 1988; 1988(226): 6 - 6. [Full Text]